Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Share News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: Phorm Jumps; Supermarkets Rebound

Thu, 03rd Oct 2013 11:39

LONDON (Alliance News) - The following stocks are the leading risers and fallers on the main London indices midday Thursday.

-------

FTSE 100 - Winners

Aviva shares, up 2.5%, are the biggest risers on the blue-chip index. The financial services provider announced Wednesday that it had completed the sale of its US operations to Athene Holding Ltd in a deal worth USD2.6 billion, some USD800 million more than previously announced.

J Sainsbury, up 1.2%, and Tesco, up 1%, are big gainers. The food retailers are rebounding from Wednesday's lows after investors reacted negatively to their trading statements. Sainsbury's is benefiting from Nomura increasing its price target to 370 pence from 350p. Similarly, Citigroup upgraded Tesco to Neutral from Sell, raising its price target to 350 from 285. However, Deutsche Bank, JP Morgan and Macquarie have all cut Tesco's price target. Both companies are trading close to pre-announcement levels.

BP climbs 0.9% after the Financial Times reported Thursday that it had reached a milestone in its legal battle to limit its compensation settlement for the 2010 Deepwater Horizon disaster. The FT announced that the oil and gas company had received a favourable ruling from a US court. The court on Wednesday night approved an injunction to stop payments to businesses that had not "experienced actual injury traceable to loss" from the Deepwater Horizon accident, overturning an earlier decision. The ruling may improve BP's chances of preventing the cost of the settlement rising beyond double its original estimate of USD7.8 billion.

-------

FTSE 100 - Losers

Sports Direct International, down 2%. The company announced that Chief Executive Officer Dave Forsey and Group Finance Director Bob Mellors, exercised options granted to them under the company's executive bonus share scheme, by acquiring 1.0 million shares and then each selling 950,000 them at a price of 680.0 pence per share on Wednesday. The 50,000 shares each retained by Forsey and Mellors are their only holdings in sporting good company, representing 0.01% stakes.

William Hill falls 1.5% after the company warned that gross win margins in sports betting were below the year before. In its interim management statement for the 13 weeks ended October 1, the company said its overall quarterly performance was impacted by quiet July trading in Retail together with lower results-linked gross win margins in the quarter. Analysts at Numis remain upbeat, but note that profits have fallen short of expectations by GBP20 million.

Standard Chartered drops 0.9% in the aftermath of Numis downgrading its recommendation. Numis cuts Standard Chartered's recommendation to Hold from Add, decreasing its price target to 1,500 pence from 1,780p. The downgrades are made as Numis reduces its 2013-2014 forecasts for Standard Chartered by 5%. Currency depreciation across a large number of Standard Chartered's operational territories has hit the international banking group hard. Numis estimates that currency alone reduces estimates by 2%. Weak third-quarter financial markets volumes also are to blame.

-------

FTSE 250 - Winners

BTG, up 1.4%. The healthcare company raised its full-year revenue guidance due to recent acquisitions it has made and said its performance the first half of the year had met its expectations. It now expects revenues in the year to March 31, 2014 to be between GBP275 million and GBP285 million, up from previous guidance of between GBP235 million and GBP245 million, after making progress in integrating the targeted therapies division of Nordion Inc., and EKOS Corporation, deals that it completed in July. In a trading update, the company said new varicose vein treatment Varisolve is still progressing through a new drug application review in the US, and it is pushing ahead with preparations for a commercial launch in the first six months of the 2014 calendar year.

-------

FTSE 250 - Losers

Ophir Energy, down 4%. The oil-and-gas producer said Wednesday that it had successfully completed the Pweza-3 appraisal well and flow test in Block 4, Tanzania. However, the stock falls for a second day as the market has little interest in appraisals until there are further farm-out announcements, says Cannacord analyst Charlie Sharp. A farm-out announcement is an agreement to outsource production of discoveries, rather than simply reporting the discoveries.

-------

AIM - Winners

Phorm Corporation, up 64%. The company has been boosted after it said that it had launched operations of its advertising platform in mainland China. The internet personalisation technology company has begun a nationwide opt-in process, and in its first week of operations has seen an average of 4.3 million users a day. It said that it was in negotiations with publishers and advertisers and had begun the commercialisation process of its operations. In the coming months the company will start its test campaigns, it said, before moving to commercial operations.

Desire Petroleum climbs 31%. Falkland Oil and Gas Limited and Desire Petroleum PLC have announced that they have reached an GBP61 million agreement for Falkland to acquire the entire share capital of Desire in exchange for FOGL shares. The oil and gas exploration and development companies, both operating in the Falkland Island Basins, said that both boards believe the deal will diversify the activities of both companies and improve finances. Following the deal, FOGL shareholders will own 60% of the combined group share capital with Desire shareholders owning the remaining 40%.

Evocutis shares jump 24% as the company rebounds from Wednesday's lows. Evocutis was a big faller Wednesday as it announced that it is to convene a general meeting on October 28 after its net assets fell to less than half of its share capital. The company said that it was no longer in discussions with potential offerers in relation to a merger or sale of the company. Evocutis shares are still a long way off pre-announcement levels.

Quoram is up 16% despite making a GBP2.0 million pretax loss for the year to June 30, compared with a loss of GBP728,000 last year. The company has announced that it is confident about the prospects for its first investment since making the transition from oil-and-gas explorer to investing company, AIM-listed Plant Health Care PLC. Quoram said Plant Health Care, which makes products that increase crop yields, could benefit from the rise in the world's population to over seven billion people and the subsequent increase in demand for food.

Alecto Minerals, up 16%. The African-focussed multi-commodity exploration and development company is widely expected to complete the acquisition of AME West Africa from Savannah Resources in the next few days.

Byotrol is up 9.8 % after it said it has entered into an agreement to acquire all of the issued shares that it does not currently own in its consumer products joint venture, Byotrol Consumer Products Limited. Byotrol Consumer Products was established in 2007 as a joint venture between Byotrol and ?What If! Innovation Capital Nominees Limited.

Varirx is up 8.1% on the back of the news that it has filed a Phase IB/dose escalation study for its anti-cancer therapeutic, VAL201. This filing is required before approval is able to be granted. ValiRx said the trial on prostate cancer patients will be a first in-man study with real patients and will not require health volunteers. A first in-man study is a clinical trial where a medical procedure, previously developed and assessed through in vitro or animal testing, or through mathematical modelling is tested on human subjects for the first time.

-------

AIM - Losers

Albemarle & Bond, down 11%, continues to fall, albeit at a slower rate, after it announced Wednesday that it was in talks with its lenders about solving potential breaches of its debt covenants later this year after discussion with its largest shareholder about an equity raising failed.

Noricum Gold is down 11% as investors react badly to the news that it has raised GBP2 million to develop its Rotgulden Gold and Precious Metals project in Austria. The gold exploration and development company said it raised the cash via an oversubscribed placing of 200 million new ordinary shares, diluting the price of existing shares.

-------

By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
3 Apr 2024 10:59

TRADING UPDATES: Quiz sales fall, names new CEO; Byotrol eyes AIM exit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
28 Mar 2024 11:00

AIM WINNERS & LOSERS: SIMEC gets payment; Molecular Energies to delist

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
7 Dec 2023 11:49

Byotrol shares jump as optimistic despite half-year loss widening

(Alliance News) - Byotrol PLC on Thursday reported an optimistic outlook amid a widened interim loss.

Read more
23 Nov 2023 12:14

Mirriad Advertising confirms Nic Hellyer has joined as new CFO

(Alliance News) - Mirriad Advertising PLC on Thursday confirmed Nic Hellyer has joined as chief financial officer.

Read more
14 Nov 2023 14:21

TRADING UPDATES: Byotrol interim sales flat; Argo loss narrows

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Oct 2023 14:13

IN BRIEF: Mirriad Advertising hires Pelatro's Nic Hellyer as new CFO

Mirriad Advertising PLC - London-based provider of in-content advertising technology - Announces appointment of Nicholos Hellyer as chief financial officer designate. Current CFO David Dorans will remain at Mirriad for the time being "to undertake an orderly handover and ensure a smooth transition to the new structure." Hellyer will join Mirriad's board in November. He was previously CFO at customer engagement software provider Pelatro PLC, resigning in late August after over six years in the role. Prior to this he was CFO at New York-based Bannix Acquisition Corp from February 2021 to October 2022, and at Chester, England-based antimicrobial technology developer Byotrol PLC from May 2019 to December 2021.

Read more
27 Sep 2023 13:20

Byotrol CEO Pinto steps down; ex-CEO appointed as interim

(Alliance News) - Byotrol PLC on Wednesday said its Chief Executive Officer Vivan Pinto has stepped down.

Read more
7 Sep 2023 15:26

Byotrol maintains strategy amid some revenue struggles

(Sharecast News) - Byotrol updated the market on its trading on Thursday, after announcing full-year results in line with expectations in July, reporting that there had been no shift in its approach to its operating strategy going forward.

Read more
7 Sep 2023 13:44

IN BRIEF: Byotrol predicts lower revenue as European growth slows

Byotrol PLC - Chester, England-based manufacturer of biocidal and antimicrobial cleaning products - Reiterates its results for the year ending March 31 are in line with its expectations for sales of GBP.46 million and earnings before interest, tax, depreciation and amortisation loss of GBP700,000. Adds its operating strategy remains unchanged as it focuses on achieving regulatory approval for its Cruise platform across Europe by early 2025. It also confirms "good progress" in its new Anigene and Chemgene MedLab formulations, as well as its Cruise technology platform. Nevertheless, says revenue has fallen behind expectations due to slower growth in product sales as well as the discontinuation of legacy products.

Read more
1 Sep 2023 15:54

UK earnings, trading statements calendar - next 7 days

Monday 4 September 
Ashtead Technology Holdings PLCHalf Year Results
Belvoir Group PLCHalf Year Results
Tuesday 5 September 
Alumasc Group PLCFull Year Results
Ashtead Group PLCQ1 Results
Blackbird PLCHalf Year Results
Craneware PLCFull Year Results
DS Smith PLCTrading Statement
Ecora Resources PLCHalf Year Results
Eurocell PLCHalf Year Results
Gamma Communications PLCHalf Year Results
GetBusy PLCHalf Year Results
Headlam Group PLCHalf Year Results
Johnson Service Group PLCHalf Year Results
Luceco PLCHalf Year Results
Michelmersh Brick Holdings PLCHalf Year Results
Midwich Group PLCHalf Year Results
Pebble Group PLCHalf Year Results
Shearwater Group PLCFull Year Results
SigmaRoc PLCHalf Year Results
STV Group PLCHalf Year Results
Tissue Regenix Group PLCHalf Year Results
Wednesday 6 September 
Apax Global Alpha LtdHalf Year Results
Ashmore Group PLCFull Year Results
Bakkavor Group PLCHalf Year Results
Barratt Developments PLCFull Year Results
Darktrace PLCFull Year Results
Halfords Group PLCTrading Statement
Hochschild Mining PLCHalf Year Results
M Winkworth PLCHalf Year Results
Malin Corp PLCHalf Year Results
Nexteq PLCHalf Year Results
Oxford Nanopore Technologies PLCHalf Year Results
Restaurant Group PLCHalf Year Results
WH Smith PLCTrading Statement
Thursday 7 September 
Angle PLCHalf Year Results
Beazley PLCHalf Year Results
Cairn Homes PLCHalf Year Results
Currys PLCTrading Statement
Direct Line Insurance Group PLCHalf Year Results
Energean PLCHalf Year Results
Funding Circle Holdings PLCHalf Year Results
Genus PLCFull Year Results
Hilton Food Group PLCHalf Year Results
Inspecs Group PLCHalf Year Results
International Public Partnerships LtdHalf Year Results
Lords Group Trading PLCHalf Year Results
Melrose Industries PLCHalf Year Results
Mpac Group PLCHalf Year Results
Playtech PLCHalf Year Results
Polarean Imaging PLCHalf Year Results
Safestore Holdings PLCTrading Statement
Synthomer PLCHalf Year Results
Vistry Group PLCHalf Year Results
WAG Payment Solutions PLCHalf Year Results
Friday 8 September 
Berkeley Group Holdings PLCTrading Statement
Byotrol PLCFull Year Results
Computacenter PLCHalf Year Results
EJF Investments LtdHalf Year Results
Petershill Partners PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
1 Sep 2023 15:54

UK shareholder meetings calendar - next 7 days

Monday 4 September 
Concurrent Technologies PLCGM re acquisition of Phillips Machine & Welding Co Inc
Tuesday 5 September 
Brickability Group PLCAGM
DS Smith PLCAGM
Iomart Group PLCAGM
Lookers PLCGM and court meeting re takeover by Global Auto
MGC Pharmaceuticals LtdGM re approval to issue SPP and shortfall options
Renold PLCAGM
Wednesday 6 September 
Alpha Financial Markets Consulting PLCAGM
Ashtead Group PLCAGM
Halfords Group PLCAGM
Mears Group PLCGM re cancellation of the share premium account
Omega Diagnostics Group PLCAGM
Severfield PLCAGM
Solid State PLCAGM
Taylor Maritime Investments LtdAGM
Yellow Cake PLCAGM
Thursday 7 September 
Chariot LtdAGM
Chaarat Gold Holdings LtdGM re sale of Chaarat Kapan
Currys PLCAGM
De La Rue PLCAGM
ECO Animal Health Group PLCAGM
Jet2 PLCAGM
LXI REIT PLCAGM
Mulberry Group PLCAGM
Powerhouse Energy Group PLCAGM
Semper Fortis Esports PLCAGM
Sivota PLCGM re directors' remuneration policy
Speedy Hire PLCAGM
Wise PLCAGM
XPS Pensions Group PLCAGM
Friday 8 September 
Berkeley Group Holdings PLCAGM
Byotrol PLCAGM
Gear4Music PLCAGM
JLEN Environmental Assets Group LtdAGM
Kenmare Resources PLCEGM re proposed tender offer
Mid Wynd International Investment Trust PLCAGM
SVM UK Emerging Fund PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
29 Aug 2023 12:06

IN BRIEF: Byotrol launches disinfectants for emergency services, labs

Byotrol PLC - Chester, England-based manufacturer of biocidal and antimicrobial cleaning products - Announces launch of "next-generation" Chemgene Medlab range of multi-surface disinfectants for emergency services, laboratories and human health organisations. Products are designed for "low toxicity and regulatory approval across the UK and EU under the increasingly stringent biocidal regulations". Byotrol says the disinfectants are "very effective" against various bacteria, yeasts, fungi and viruses including Candidia Auris, the norovirus and the coronovirus. The Chemgene brand was previously marketed by Medimark Scientific Ltd and acquired by Byotrol in 2018.

Read more
31 Jul 2023 19:47

TRADING UPDATES: Byotrol loss widens, Surface Transforms sales grow

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
6 Jul 2023 10:40

Byotrol shares up as wins patent for novel anti-viral seaweed extract

(Alliance News) - Byotrol PLC shares jumped on Thursday, after it said it has won a UK patent for novel anti-viral seaweed extract.

Read more
24 May 2023 16:28

IN BRIEF: Byotrol soars as US EPA backs virucidal claims for sanitiser

Byotrol PLC - Chester, England-based developer of antimicrobial technologies and products - Announces US Environmental Protection Agency has approved long-lasting virucidal claims for its proprietary 24-hour germ-kill surface sanitiser Byotrol 24. Believes this is the first product to receive such EPA approval and means that Byotrol24 and its sub brands will now be able to offer unique and highly relevant claims and performance characteristics to US consumers and businesses. This includes being able to claim efficacy against current and emerging viral pathogens including influenza, coronavirus and norovirus. Continues to advance alliances and commercial opportunities in the US. Executive Director David Traynor says: "This is fantastic news for Byotrol and confirms the excellence of our US surface sanitizers."

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.